Early research (Phase 1)Study completedNCT01208454
What this trial is testing
Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma
Who this might be right for
Localized Unresectable NeuroblastomaRecurrent NeuroblastomaRegional Neuroblastoma+2 more
National Cancer Institute (NCI) 29